Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Allen Kuo

Psychiatry Barrington, IL Doctor of Osteopathy

NPI 1255308565 CMS profile 569507

1000 Hart Rd, Ste 130, Barrington, IL 60010

Open in the dashboard

General payments

$7,223

362 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Allen Kuo of Barrington, IL is reported in the CMS Open Payments database as having received $7,223 across 362 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,902 84
2024 General $1,596 73
2023 General $1,254 60
2022 General $741 40
2021 General $703 38
2020 General $343 20
2019 General $683 47

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Allen Kuo
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Allen Kuo were reported at $1,902. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Allen Kuo Psychiatry median Middle half National median
2019 $683 $184 $59–$605 $163
2020 $343 $119 $36–$372 $114
2021 $703 $143 $43–$576 $132
2022 $741 $153 $50–$590 $149
2023 $1,254 $170 $56–$651 $160
2024 $1,596 $179 $57–$673 $164
2025 $1,902 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $1,037 63 payments
  2. Lundbeck LLC $619 31 payments
  3. Otsuka America Pharmaceutical, Inc. $535 26 payments
  4. Janssen Pharmaceuticals, Inc $496 18 payments
  5. ITI, Inc. $483 22 payments
  6. Vanda Pharmaceuticals Inc. $464 20 payments
  7. Corium, Inc. $448 21 payments
  8. Takeda Pharmaceuticals U.S.A., Inc. $379 24 payments
  9. Alkermes, Inc. $378 18 payments
  10. Teva Pharmaceuticals USA, Inc. $314 9 payments
  11. Other $2,069 110 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $7,093 359 payments
  2. Education $130 3 payments
Products named General payments · program years 2019–2025
  1. VRAYLAR Neuroscience $798 50 payments
  2. REXULTI Psychiatry $498 24 payments
  3. SPRAVATO $496 18 payments
  4. FANAPT $464 20 payments
  5. Azstarys $448 21 payments
  6. REXULTI Psychiatry $414 17 payments
  7. VRAYLAR Neuroscience $381 23 payments
  8. LYBALVI $378 18 payments
  9. CAPLYTA $328 14 payments
  10. ARISTADA $314 15 payments
  11. Other $4,520 227 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 60 drugs

Part D claims

5,962

Median for Psychiatry: 574

Drug cost

$258,301

Median for Psychiatry: $27,624

Branded share of claims

16.3%

Median for Psychiatry: 17%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Rexulti Brexpiprazole Brand 28 $50,166
Aripiprazole Generic 223 $27,898
Clozapine Generic 197 $24,277
Lybalvi Olanzapine/Samidorphan Malate Brand 12 $20,442
Divalproex Sodium Generic 131 $11,996
Trintellix Vortioxetine Hydrobromide Brand 21 $9,882
Divalproex Sodium Er Divalproex Sodium Brand 109 $8,199
Quetiapine Fumarate Generic 378 $7,971
Paliperidone Er Paliperidone Brand 22 $7,594
Fluvoxamine Maleate Generic 120 $7,193

The 10 drugs with the highest cost, of 60 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 20,488 Part D prescribers listed as Psychiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 4 billing codes

Paid by Medicare

$51,486

Medicare's payments for the services billed

Medicare patients

250

Average age 61

Services billed

995

144 women, 106 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Depression 59%
High blood pressure 54%
Arthritis 36%
Diabetes 34%
Osteoporosis 14%
Chronic kidney disease 13%
Ischemic heart disease 12%
Cancer 11%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 17 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
REXULTI
  • Lundbeck LLC $204
  • Otsuka America Pharmaceutical, Inc. $204
$408 28 —
VRAYLAR
  • AbbVie, Inc. $194
$194 — —
Auvelity
  • Axsome Therapeutics, Inc. $151
$151 — —
Adzenys XR-ODT
  • Neos Therapeutics, LP $108
$108 — —
CAPLYTA
  • ITI, Inc. $105
$105 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 17 in the dashboard with a free account

Records

362 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record